| MeSH term | MeSH ID | Detail |
|---|---|---|
| Tuberculosis, Multidrug-Resistant | D018088 | 6 associated lipids |
| Starvation | D013217 | 47 associated lipids |
Total
2
D-cycloserine
D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.
Cross Reference
Introduction
To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with D-cycloserine?
D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with D-cycloserine
PubChem Associated disorders and diseases
What pathways are associated with D-cycloserine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with D-cycloserine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with D-cycloserine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with D-cycloserine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with D-cycloserine?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with D-cycloserine?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with D-cycloserine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Leat JL and Marks J | Improvement of drg-sensitivity tests on tubercle bacilli. | 1970 | Tubercle | pmid:4099827 |
| Jesiotr M | Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis. | 1969 | Tubercle | pmid:4319133 |
| Crofton J | Treatment of patients with drug-resistance in economically developed countries. | 1969 | Tubercle | pmid:4319134 |
| De ville de Goyet CA and Kleeberg HH | Technical and bacteriological aspects of a continuous survey of drug resistance in tuberculosis in South Africa. | 1972 | Tubercle | pmid:4114098 |
| Velu S and Sambamoorthy S | A note on the relapse rate over a four-year period in patients with quiescent pulmonary tuberculosis following treatment with reserve regimens. | 1968 | Tubercle | pmid:5716380 |
| ZIERSKI M | TREATMENT OF PATIENTS WITH CULTURES RESISTANT TO THE PRIMARY ANTI-TUBERCULOSIS DRUGS. | 1964 | Tubercle | pmid:14161919 |
| ANGEL JH et al. | A controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy. | 1963 | Tubercle | pmid:14013125 |
| KASS I | CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. I. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF KANAMYCIN, ETHIONAMIDE AND EITHER CYCLOSERINE OR PYRAZINAMIDE. | 1965 | Tubercle | pmid:14327963 |
| KASS I | CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE. | 1965 | Tubercle | pmid:14327964 |
| RAO KV et al. | A SIMPLE TEST FOR THE DETECTION OF PYRAZINAMIDE AND CYCLOSERINE IN URINE. | 1965 | Tubercle | pmid:14327968 |